Cite
A constrained maximum likelihood approach to evaluate the impact of dose metric on cancer risk assessment: application to β-chloroprene.
MLA
Allen, B. C., et al. “A Constrained Maximum Likelihood Approach to Evaluate the Impact of Dose Metric on Cancer Risk Assessment: Application to β-Chloroprene.” Regulatory Toxicology and Pharmacology : RTP, vol. 70, no. 1, Oct. 2014, pp. 203–13. EBSCOhost, https://doi.org/10.1016/j.yrtph.2014.07.001.
APA
Allen, B. C., Van Landingham, C., Yang, Y., Youk, A. O., Marsh, G. M., Esmen, N., Gentry, P. R., Clewell, H. J., 3rd, & Himmelstein, M. W. (2014). A constrained maximum likelihood approach to evaluate the impact of dose metric on cancer risk assessment: application to β-chloroprene. Regulatory Toxicology and Pharmacology : RTP, 70(1), 203–213. https://doi.org/10.1016/j.yrtph.2014.07.001
Chicago
Allen, B C, C Van Landingham, Y Yang, A O Youk, G M Marsh, N Esmen, P R Gentry, H J Clewell 3rd, and M W Himmelstein. 2014. “A Constrained Maximum Likelihood Approach to Evaluate the Impact of Dose Metric on Cancer Risk Assessment: Application to β-Chloroprene.” Regulatory Toxicology and Pharmacology : RTP 70 (1): 203–13. doi:10.1016/j.yrtph.2014.07.001.